ClinicalTrials.gov identifier: NCT01679873International audienceBACKGROUND: Systematic reporting of funding sources is recommended in the CONSORT Statement for abstracts. However, no specific recommendation is related to the reporting of conflicts of interest (CoI). The objective was to compare physicians' confidence in the conclusions of abstracts of randomized controlled trials of pharmaceutical treatment indexed in PubMed. METHODS: We planned a three-arm parallel-group randomized trial. French general practitioners (GPs) were invited to participate and were blinded to the study's aim. We used a representative sample of 75 abstracts of pharmaceutical industry-funded randomized controlled trials published in 2010 and indexed in PubMed. Eac...
Artículo de publicación ISIBackground. The relationship between industry funding and study results ...
Transparency in reporting of conflict of interest is an increasingly important aspect of publication...
Over the past three decades, industry sponsored research expanded in the United States. Financial in...
ClinicalTrials.gov identifier: NCT01679873International audienceBACKGROUND: Systematic reporting of ...
Background: Systematic reporting of funding sources is recommended in the CONSORT Statement for abst...
Context Disclosure of conflicts of interest (COIs) from pharmaceutical industry study funding and au...
Abstract CONTEXT: Disclosure of conflicts of interest (COIs) from pharmaceutical industry study fund...
Reporting funding source or conflict of interest in abstracts of randomized controlled trials, no (−...
Purpose: We sought to determine the prevalence, reliability, and predictors of conflict of interest ...
BackgroundDiscrepancies between information in conference abstracts and full publications describing...
Objectives: This study examines financial conflict-of-interest (FCOI) of clinicians who made submiss...
Guideline recommendations may be biased due to conflicts of interest (COI) of panel members and spon...
Medical studies are more likely to report favorable findings when a conflict of interest is declared...
ObjectivesThis study assessed whether the results of major, potentially practice-altering cardiovasc...
Artículo de publicación ISIBackground. The relationship between industry funding and study results ...
Transparency in reporting of conflict of interest is an increasingly important aspect of publication...
Over the past three decades, industry sponsored research expanded in the United States. Financial in...
ClinicalTrials.gov identifier: NCT01679873International audienceBACKGROUND: Systematic reporting of ...
Background: Systematic reporting of funding sources is recommended in the CONSORT Statement for abst...
Context Disclosure of conflicts of interest (COIs) from pharmaceutical industry study funding and au...
Abstract CONTEXT: Disclosure of conflicts of interest (COIs) from pharmaceutical industry study fund...
Reporting funding source or conflict of interest in abstracts of randomized controlled trials, no (−...
Purpose: We sought to determine the prevalence, reliability, and predictors of conflict of interest ...
BackgroundDiscrepancies between information in conference abstracts and full publications describing...
Objectives: This study examines financial conflict-of-interest (FCOI) of clinicians who made submiss...
Guideline recommendations may be biased due to conflicts of interest (COI) of panel members and spon...
Medical studies are more likely to report favorable findings when a conflict of interest is declared...
ObjectivesThis study assessed whether the results of major, potentially practice-altering cardiovasc...
Artículo de publicación ISIBackground. The relationship between industry funding and study results ...
Transparency in reporting of conflict of interest is an increasingly important aspect of publication...
Over the past three decades, industry sponsored research expanded in the United States. Financial in...